Get the Stockscreener App
0.297
3.48%
0.01
After Hours:
.29
-0.007
-2.36%
Why is Bioline Rx Ltd Adr (BLRX) Stock down?
We've noticed a 13.97% decline in Bioline Rx Ltd Adr (BLRX) stock during the 2024-11-22 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
20 Nov, 2023:
Shares of BioLineRx (BLRX) dropped by 10.59% from $1.700 to $1.520 in the trading on Monday, November 20, 2023. The reason why BLRX is down today is due to the company's disappointing Q3 financial results.
- Research and development expenses decreased by 37.6%, mainly due to reduced costs associated with NDA supporting activities and the completed AGI-134 clinical trial.
- Sales and marketing expenses saw a significant 517.4% increase, driven by heightened pre-commercialization activities.
- General and administrative expenses rose by 7.7% due to minor increases in various G&A expenses.
- Non-operating expenses surged, primarily due to the revaluation of outstanding warrants caused by an increase in the company's share price.
- Net losses for both the three and nine months ended September 30, 2023, were significantly higher compared to the same periods in 2022.
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):